Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | VP GM Advanced Surgical | March 02, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date March 02, 2026 · Filed March 18, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2036-03-02 | Direct | 17,471 |
Reported balance
After 2026-03-02 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 17,471 · Balance 17,471 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,827 shares for a total of 17,471 RSUs granted. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
F2: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,827 shares for a total of 17,471 RSUs granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 4, 2026 21:04 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 11,646 | $0.00 Strike: $45.79 | $0.00 |
DisclosureSEC source: 0000816956-26-000027 · form4.xml · derivative · entry 2 Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,646 Underlying: Common Stock · 11,646 shares Expires 2036-03-02 F2 · derivative.exercise_date: The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:04 UTC | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 9,827 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000027 · form4.xml · derivative · entry 1 Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,827 Underlying: Common Stock · 9,827 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. Read SEC document |
| March 02, 2026 Filed Mar 18, 2026 18:04 UTC Amendment | CONMED Corp CNMD · Entity 4691 | GrantRSUs (Restricted Stock Units) · Derivative | 17,471 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000816956-26-000037 · form4a.xml · derivative · entry 1 Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,471 Underlying: Common Stock · 17,471 shares Expires 2036-03-02 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year. F2 · derivative.underlying_shares: This Form 4/A is filed solely to correct the amount of RSUs granted. A special award of 7,644 shares was awarded in addition to the originally reported 9,827 shares for a total of 17,471 RSUs granted. Read SEC document |
| April 28, 2025 Filed May 1, 2025 20:28 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 31,675 | $0.00 Strike: $50.84 | $0.00 |
DisclosureSEC source: 0001127602-25-012933 · form4.xml · derivative · entry 1 Schabacker Matthew · CIK 0002066553 · VP GM Advanced Surgical 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,675 Underlying: Common Stock · 31,675 shares Expires 2035-04-28 F1 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.